By Pinkerala News Desk | Oct 22, 2021
GenWorks Health partners with Karkinos Healthcare to impact
early detection and intervention of cervical cancer
To propagate adoption of HPV DNA test to detect minute changes in cervical cell specimens
1 in every 79 women affected in India; contributes to over 20% of cervical cancer cases in the world
Mumbai, October 21, 2021: In the spirit of the season of commemoration of women's strength and empowerment, GenWorks Health has announced a strategic partnership with Karkinos Healthcare to promote women's health and support. The partnership will encourage the adoption of the World Health Organisation’s (WHO) recommended Human Papilloma Virus (HPV) DNA test for early detection of cervical cancer among women followed by standard diagnosis and treatment. Early detection of cervical cancer has shown that treatments are less complex and less expensive, with some pre-cancers treated in simple outpatient procedures. The survival rates are much higher than if the cancer is detected in later stages.
Cervical cancer is cancer that affects 1 in every 79 Indian women, with India contributing to nearly 1/5th of all cervical cancer cases in the world, according to the GLOBOCAN report published by the International Agency on Cancer Research (IARC). Most of the women diagnosed with cervical cancer undergo complicated, expensive treatment regimens which accrue to large financial liabilities. This is due to late-stage detection, stemming from a lack of awareness of screening methodologies and paucity of access to these screening tests.
“The HPV DNA test is regarded by experts as the gold standard of screening methodologies. The Human Papilloma Virus (HPV) causes 99% of all cervical cancers, and the HPV DNA test is able to detect minute changes in cervical cell specimens, which may be indicative of high risk. If HPV test is negative, the woman does not have CIN or cervical cancer at the time of testing and highly likely that will not develop CIN or Cancer in the next 5-10 years.” said Dr. Rengaswamy Sankaranarayanan, MD & Director, Preventive Oncology at Karkinos Healthcare Pvt. Ltd.
GenWorks is a nationwide supplier of Mobile ODT’s EVA colposcopes, which offer AI diagnosis on colposcopy. This assists gynecologists to confirm with a greater level of accuracy whether a positive-screened woman has cervical precancer. GenWorks has a wide network of users in the form of the country’s leading gynecologists.
“At GenWorks, our partnerships are compelling for connecting the healthcare ecosystem for affordable access with best-in-class solutions that can provide early healthcare services. We believe our partnership with Karkinos truly complements our strategy. The partnership will help to leverage our screening and diagnostic portfolio and build connect with the treatment expertise of Karkinos to being best in class care across the country for our customers to solve for specialist access and affordable care.” said Mr. S Ganesh Prasad, Founder, MD & CEO of GenWorks Health Pvt. Ltd.
Together, Karkinos Healthcare and GenWorks will provide primary screening through HPV DNA tests, and confirmatory diagnoses through colposcopy at the clinics and hospitals of the partner gynecologists. Women may avail these services in their cities at the clinics and hospitals within the Karkinos-GenWorks network.
The tests would be made available to all women between the ages of 30 and 65 years, across India. The collaboration will aim to provide the services in every town in India, with a view to eliminating cervical cancer.
About GenWorks Health Pvt. Ltd.
GenWorks Health is an Indian healthcare technology solutions and healthcare education provider headquartered in Bangalore, Karnataka, India. GenWorks was founded in 2015 in the care areas of mother & child, critical care, cardiology, & radiology. Our portfolio included hospital solutions for treatment. Aligned to our early health vision of affordable care, we have built a strong portfolio for screening & diagnostics. With our digital tech platform, we can fast-track scale & efficiency to support customer growth. We are expanding our care areas to cancer screening, nephrology, ENT, respiratory, and many more care areas supported by a team of 500 + members in 130 + locations across India. For more information, visit https://www.genworkshealth.com/our-company/
About Karkinos Healthcare Pvt. Ltd.
Karkinos Healthcare is technology-driven oncology focussed managed health care platform for the early detection and diagnosis of common cancers. The company espouses the use of a distributed cancer care network working with multiple healthcare institutions and professionals in the ecosystem with a view to getting cancer care closer to the persons’ homes by decoupling the delivery from the knowledge systems of care. For more information, visit https://www.karkinos.in/about-us/
For more information please contact:
firstname.lastname@example.org | 9830035203
email@example.com | 8861210977
By Pinkerala | Dec 04, 2021IndusInd Bank launches NRI Homecoming festival
By Pinkerala | Dec 03, 2021SBI partners with Adani Capital for co-lending to farmers
By Pinkerala | Dec 03, 2021Swiss CxOs Rank TCS #1 in Customer Satisfaction in Indepteamendent Survey
By Pinkerala | Dec 03, 2021